Execution of the final treasury (founders’) share purchase agreement by the Company
22.04.2026
See also
Synektik plans to devide. It is spinning off the cardiotracer research project into a new company which will also be listed on the WSE
- Corporate news
- Investor relations
The division of Synektik is complete – the court has registeredthe issue of Syn2bio shares
- Corporate news
- Investor relations
Syn2bio now on the stock exchange
- Corporate news
- Investor relations